COVID-19 vaccines will work in opposition to new variants of the virus detected within the UK and South Africa and there’s no proof that present vaccines will fail to guard in opposition to these coronavirus variants, Prof Okay Vijay Raghavan, Principal Scientific Advisor (PSA) to the Government of India, has mentioned.
The authorities mentioned that the UK variant of the virus is extra “transmissible”. “Vaccines will work against the variants detected in the UK and South Africa. There is no evidence that current vaccines will fail to protect against these COVID-19 variants. The UK variant of the virus is more “transmissible”,” Raghavan mentioned in a press convention.
Stating that there are issues as most vaccines goal the Spike protein, during which there are modifications within the variants, he mentioned: “Vaccines stimulate our immune system to produce a wide range of protective antibodies. The changes in the variants are not sufficient to make the vaccines ineffective.”
The official asserted that additional precautionary measures are should to stop these sorts of variants to dominate our inhabitants.
There are six COVID-19 vaccines in numerous scientific trial levels in India. Besides, three vaccine candidates are in pre-clinical trial levels. Pfizer, Serum Institute of India (SII) and Bharat Biotech have sought emergency use authorisation of their COVID-19 vaccines.
The United Kingdom turned the primary nation on the earth to manage the brand new coronavirus vaccine developed collectively by Pfizer and BioNTech. Canada, Mexico, the US are among the many nations that later accredited the Pfizer-BioNTech Covid-19 vaccine for his or her residents.
The PSA additional mentioned that the federal government was conducting testing and sequencing of samples from worldwide travellers in addition to samples of these being admitted to hospitals.